Older people who carry the apolipoprotein E epsilon-4 allele (APOE e4) gene experience a significantly faster decline in cognitive function, particularly after the age of 70, research released on ...

EATING plenty of meat could be linked to lower dementia risk – but only for 25 per cent of Brits. Adults at higher risk of ...

Some people with the gene did not have expected outcomes if they were heavy meat-eaters ...

ApoE4.Info, Inc and the ApoE4 Alzheimer's Alliance (A3) today announced a strategic partnership to elevate research, education, and public policy efforts focused on individuals who carry the ε4 allele ...

Recently published Epidermolysis Bullosa Market Insights report includes a comprehensive understanding of current treatment practices, epidermolysis bullosa emerging drugs, market share of individual ...

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a PARP inhibitors for prostate cancer session and a presentation by Dr. Himisha Beltran discussing how to read a ...

The growth of the epidermolysis bullosa market is expected to be mainly driven by increasing prevalence, patient awareness, label expansion of approved therapies, high cost of therapies, and ...

The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4 ...

Wolves living inside the Chernobyl Exclusion Zone show genetic and immune-system signals that researchers say may be linked ...

The groups are calling for genotype-informed prevention and treatment strategies, APOE stratification in clinical trials, and related public policies.

Atara Biotherapeutics ( (ATRA)) just unveiled an announcement. On March 3, 2026, Atara Biotherapeutics reported that its partner Pierre Fabre Pharmaceuticals has requested a Type A meeting with the ...

Spread the loveOn March 14, 2026, developmental biologists Davor Solter and Azim Surani were honored with the esteemed Paul Ehrlich and Ludwig Darmstaedter Prize, accompanied by a generous award of ...